Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States - 20/06/23
Doi : 10.1016/j.jaad.2023.02.009
Jeremy A.W. Gold, MD a, ⁎ 
, Kaitlin Benedict, MPH a, Theresa M. Dulski, MD b, Shari R. Lipner, MD, PhD c
, Kaitlin Benedict, MPH a, Theresa M. Dulski, MD b, Shari R. Lipner, MD, PhD c a Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
b Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia
c Department of Dermatology, Weill Cornell Medicine, New York, New York
∗Correspondence and reprint requests to: Jeremy A.W. Gold, MD, Mycotic Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-10, Atlanta, GA 30329Mycotic Diseases BranchCenters for Disease Control and Prevention1600 Clifton Rd NE, Mailstop H24-10AtlantaGA30329
Key words : antifungal stewardship, antifungal susceptibility testing, culture, dermatophyte, direct microscopy, epidemiology, fluconazole, griseofulvin, itraconazole, ketoconazole, polymerase chain reaction, terbinafine, tinea capitis, treatment, United States
| Funding sources: None. |
|
| Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. |
|
| Note: This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy (for example, 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq). |
|
| IRB approval status: Not applicable. |
© 2023
Publié par Elsevier Masson SAS.
Vol 89 - N° 1
P. 133-135 - juillet 2023 Retour au numéro
Article précédent
- Improving access to dermatology for underserved regions of South Dakota: A need assessment
- Jazmin Newton, Channi Silence, Medha Rao, Rebecca Vasquez, Darrell Plumage, Siobhan Wescott, Matthew Tobey, Arianne Shadi Kourosh
- Narrowband ultraviolet B phototherapy in pediatric vitiligo: A retrospective study
- Anna Cristina Garza-Mayers, Gabriella M. Paquette, John E. Harris, Karen Wiss
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?